Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3827.35 (Glytoucan)

Id:deed9b23-162c-5da8-bb75-90ebbb43ae7f

Glytoucan:G97039HI

Results found

Linked to

	Label	Description
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G28231AL-GLYCOSEQ00165438 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has canonical residue n-glycan a-d-neupnac 16 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G09877AJ-GLYCOSEQ00194161 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G21737WY-GLYCOSEQ00195632 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000109 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G38960EZ-GLYCOSEQ00051817 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G97039HI-GLYCOSEQ00201288 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has canonical residue n-glycan a-d-neupnac 12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G64822OJ-GLYCOSEQ00043412 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G08838KS-GLYCOSEQ00102813 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G28231AL-GLYCOSEQ00165438 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has canonical residue n-glycan a-d-neupnac 16

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G09877AJ-GLYCOSEQ00194161 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G21737WY-GLYCOSEQ00195632 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000109 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G38960EZ-GLYCOSEQ00051817 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G97039HI-GLYCOSEQ00201288 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has canonical residue n-glycan a-d-neupnac 12

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G64822OJ-GLYCOSEQ00043412 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3827.35 has glycosequence GLYGEN.GLYCOSEQUENCE:G08838KS-GLYCOSEQ00102813 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.